INTERACTION OF THE D1-RECEPTOR ANTAGONIST SCH-23390 WITH THE CENTRAL 5-HT SYSTEM - RADIOLIGAND BINDING-STUDIES, MEASUREMENTS OF BIOCHEMICAL PARAMETERS AND EFFECTS ON L-5-HTP SYNDROME

被引:37
|
作者
BISCHOFF, S [1 ]
HEINRICH, M [1 ]
KRAUSS, J [1 ]
SILLS, MA [1 ]
WILLIAMS, M [1 ]
VASSOUT, A [1 ]
机构
[1] CIBA GEIGY CORP,DIV DRUG DISCOVERY,SUMMIT,NJ 07901
来源
JOURNAL OF RECEPTOR RESEARCH | 1988年 / 8卷 / 1-4期
关键词
D O I
10.3109/10799898809048981
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:107 / 120
页数:14
相关论文
共 2 条
  • [1] SCH-23390 - A SELECTIVE DOPAMINE D-1 RECEPTOR ANTAGONIST WITH PUTATIVE 5-HT1 RECEPTOR AGONISTIC ACTIVITY
    SKARSFELDT, T
    LARSEN, JJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (03) : 389 - 395
  • [2] Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin
    DiPalma, Devon
    Rezvani, Amir H.
    Willette, Blair
    Wells, Corinne
    Slade, Susan
    Hall, Brandon J.
    Levin, Edward D.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 176 : 16 - 22